TWELVE-MONTH INTERIM ANALYSIS OF EFFICACY AND SAFETY OF GIVOSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR ACUTE HEPATIC PORPHYRIA, IN THE ENVISION OPEN LABEL EXTENSION R. Marchi, L. Duarte, S. E, B. M, R. Dc, S. P, S. U, A.P. P, B. Dm, E. Al, K. S, P. C, P. Jd

EIGHTEEN-MONTH INTERIM ANALYSIS OF EFFICACY AND SAFETY OF GIVOSIRAN, AN RNAI THERAPEUTIC FOR ACUTE HEPATIC PORPHYRIA, IN THE ENVISION OPEN LABEL EXTENSION D Kuter, S Keel, C Parker, DC Rees, U Stölzel, P Ventura, M Balwani, L Gouya, S Rhyee, S Silver

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA A.N.L. Prezotti, K.J. Pasi, C. Négrier, M.V. Ragni, P. Georgiev, T. Lissitchkov, K. Salim, B. Mei, S. Andersson